Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

381 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274.
Galsky MD, Witjes JA, Gschwend JE, Milowsky MI, Schenker M, Valderrama BP, Tomita Y, Bamias A, Lebret T, Shariat SF, Park SH, Agerbaek M, Jha G, Stenner F, Ye D, Giudici F, Dutta S, Askelson M, Nasroulah F, Zhang J, Brophy L, Bajorin DF. Galsky MD, et al. Among authors: gschwend je. J Clin Oncol. 2024 Oct 11:JCO2400340. doi: 10.1200/JCO.24.00340. Online ahead of print. J Clin Oncol. 2024. PMID: 39393026
Criteria for Re-Irradiation.
Willmann J, Andratschke N, Klussmann JP, Gschwend JE, Tabatabai G, Niyazi M. Willmann J, et al. Among authors: gschwend je. Dtsch Arztebl Int. 2024 Nov 1;(Forthcoming):arztebl.m2024.0156. doi: 10.3238/arztebl.m2024.0156. Online ahead of print. Dtsch Arztebl Int. 2024. PMID: 39194170 Free article. Review.
[Knowledge creates evidence, healing, and innovation].
Gschwend JE, Meissner VH. Gschwend JE, et al. Urologie. 2024 Sep;63(9):848-849. doi: 10.1007/s00120-024-02412-5. Epub 2024 Aug 23. Urologie. 2024. PMID: 39177759 German. No abstract available.
Risk-adjusted Screening for Prostate Cancer-Defining the Low-risk Group by Data from the PROBASE Trial.
Krilaviciute A, Kaaks R, Seibold P, de Vrieze M, Lakes J, Radtke JP, Kuczyk M, Harke NN, Debus J, Fink CA, Herkommer K, Gschwend JE, Meissner VH, Benner A, Kristiansen G, Hadaschik B, Arsov C, Schimmöller L, Antoch G, Giesel FL, Makowski M, Wacker F, Schlemmer HP, Becker N, Albers P. Krilaviciute A, et al. Among authors: gschwend je. Eur Urol. 2024 May 15:S0302-2838(24)02358-3. doi: 10.1016/j.eururo.2024.04.030. Online ahead of print. Eur Urol. 2024. PMID: 38749854 Free article.
Biochemical Response of <0.1 ng/ml Predicts Therapy-free Survival of Prostate Cancer Patients following Prostate-specific Membrane Antigen-targeted Salvage Surgery.
Knipper S, Lischewski F, Koehler D, Eiber M, van Leeuwen FWB, de Barros H, Berrens AC, Zuur L, van Leeuwen PJ, van der Poel H, Ambrosini F, Falkenbach F, Budäus L, Steuber T, Graefen M, Tennstedt P, Gschwend JE, Horn T, Heck MM, Maurer T. Knipper S, et al. Among authors: gschwend je. Eur Urol Oncol. 2024 May 9:S2588-9311(24)00112-3. doi: 10.1016/j.euo.2024.04.019. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38729805 Free article.
381 results